文献速递肾小球疾病遗传性与小管间质肾病

Alport综合征基于基因型的分子机制

Genotype-Based Molecular Mechanisms in Alport Syndrome.
PubMed 文献 · J Am Soc Nephrol · 2025-02-03

本文综述Alport综合征基于基因型的分子机制,涉及COL4A3/COL4A4/COL4A5致病变异及α3α4α5(IV)胶原网络。不同突变类型(蛋白截短 vs 错义)导致不同分子病理:截短变异中未成熟α1α1α2(IV)网络持续存在并激活内皮素A受体,错义变异则引起胶原转运障碍和内质网应激。这些机制为精准医学方法提供基础。

要点

  • 蛋白截短变异导致α3α4α5(IV)缺失,未成熟α1α1α2(IV)网络持续存在并激活内皮素A受体。
  • 错义变异仍合成α3α4α5(IV),但体外研究提示胶原转运受损和内质网应激。
  • 整合素和DDR1等胶原受体激活参与疾病进展。

核心结论

  • Alport综合征的基因型(蛋白截短 vs 错义变异)对应不同的分子机制,是未来精准医学方法的关键。

研究设计与样本

  • 综述,汇总犬、小鼠和大鼠模型及体外研究,涵盖常染色体和X连锁遗传模式及不同突变类型。

主要发现

  • 常染色体Alport综合征(双等位基因致病变异)或男性X连锁Alport综合征伴蛋白截短变异时,不合成α3α4α5(IV)。
  • 错义变异时仍合成α3α4α5(IV),但体外研究提示胶原转运受损和内质网应激。
  • 蛋白截短变异的敲除模型提示未成熟α1α1α2(IV)网络持续存在与生物力学应变相关,激活内皮素A受体导致系膜伪足形成。
  • 胶原受体、整合素和DDR1的激活参与疾病传播。

临床怎么用

  • 根据基因型(蛋白截短 vs 错义)区分分子机制,为未来精准医学方法提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alport syndrome is an inherited disorder characterized by kidney disease, sensorineural hearing loss, and ocular abnormalities. Alport syndrome is caused by pathogenic variants in COL4A3 , COL4A4 , or COL4A5 , which encode the α 3, α 4, and α 5 chains of type 4 collagen that forms a heterotrimer expressed in the glomerular basement membrane. Knowledge of its genetic basis has informed the development of different models in dogs, mice, and rats that reflect its autosomal and X-linked inheritance patterns as well as different mutation types, including protein-truncating and missense variants. A key difference between these two types is the synthesis of α 3 α 4 α 5(IV), which is not made in autosomal Alport syndrome (two pathogenic variants in trans or biallelic) or male patients with X-linked Alport syndrome due to protein-truncating variants. By contrast, α 3 α 4 α 5(IV) is synthesized in Alport syndrome because of missense variants. For missense variants, in vitro studies suggest that these cause impaired type 4 collagen trafficking and endoplasmic reticulum stress. For protein-truncating variants, knockout models suggest that persistence of an immature α 1 α 1 α 2(IV) network is associated with biomechanical strain, which activates endothelin-A receptors leading to mesangial filopodia formation. Moreover, studies suggest that activation of collagen receptors, integrins and discoidin domain receptor 1, play a role in disease propagation. In this review, we provide an overview of how these genotype-phenotype mechanisms are key for a precision medicine-based approach in the future.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Caparali EB, De Gregorio V, Barua M, et al. Genotype-Based Molecular Mechanisms in Alport Syndrome. J Am Soc Nephrol. 2025. PMID: 39899372. doi:10.1681/ASN.0000000647

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。